InvestorsHub Logo
Followers 122
Posts 4542
Boards Moderated 1
Alias Born 02/24/2014

Re: None

Tuesday, 01/15/2019 2:57:22 PM

Tuesday, January 15, 2019 2:57:22 PM

Post# of 35412
Key takeaways from today's press on NOUV:

“Shareholders of NOUV and PURA can expect to see public filing updates this week,” committed Brian Shibley, the CEO of both companies. “I will make sure through public announcements that shareholders are kept abreast of the updates on a blow by blow basis. The cultivation business acquired by NOUV is thriving and with the recent legalization of hemp farming in the U.S. under the 2018 Farm Act, shareholders can expect to see 100 acres of hemp planted this spring adding to the existing cultivation operations. Now we need to get the NOUV corporate filings up to speed to reflect the caliber of the current operations under NOUV. After all is in compliance, we will initiate the effort of recruiting and engaging permanent senior management.”

It has been well understood that Nouveau Life Pharmaceutical's lack of filings in the last few years has kept a lid on the upward trajectory of the stock. This wall change this week as the filings will be up to date, including the recent cash infusions due to the purchase of cannabis cultivation operations (CBD and THC)

We all knew this was coming after the previous press, but this pretty much solidifies it.

Recommend accumulation at any price below .0050. Any accumulation, even if just a few million shares, might be necessary at this point.

$NOUV